K-L-O-W
KLOW
GHK-Cu • BPC-157 • TB-500 • KPV
KLOW is a research peptide blend combining four compounds that are being studied individually for their potential roles in tissue repair, inflammatory signaling, skin health, wound healing, and gastrointestinal processes.
KLOW 80 mg Blend: GHK-Cu -50 mg, BPC-157 -10 mg,TB-500 -10 mg, KPV -10 mg
BPC-157
Body Protection Compound-157 • Pentadecapeptide
BPC-157 is a synthetic peptide based on a peptide sequence associated with gastric proteins. It has been studied primarily in laboratory and animal models for its potential involvement in tissue repair, gastrointestinal protection, wound healing, and inflammatory processes.
Mechanism of Action Research suggests BPC-157 may influence angiogenesis, nitric oxide signaling, growth-factor activity, fibroblast migration, and other pathways involved in tissue repair. These proposed effects have primarily been demonstrated in preclinical research and have not been established as therapeutic benefits in humans.
Areas of Research
Tendon and ligament repair
Muscle and soft-tissue recovery
Gastrointestinal tissue protection
Wound healing
Angiogenesis and vascular signaling
Inflammatory pathways
TB-500
Thymosin Beta-4–Related Peptide
TB-500 is a synthetic peptide associated with thymosin beta-4, a naturally occurring protein involved in cell migration, actin regulation, tissue remodeling, and wound-repair processes.
Mechanism of Action Research involving thymosin beta-4 suggests that it interacts with actin and cellular migration pathways. These mechanisms have generated interest in its potential involvement in tissue remodeling, angiogenesis, wound repair, and inflammatory regulation. Research specifically involving products marketed as TB-500 remains limited.
Areas of Research
Muscle and soft-tissue repair
Cell migration
Tissue regeneration
Wound healing
Angiogenesis
Inflammatory signaling
Tendon and ligament research
KPV
Lysine-Proline-Valine
KPV is a naturally occurring three-amino-acid peptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). It has attracted research interest primarily because of its potential effects on inflammatory and immune-signaling pathways.
Mechanism of Action Preclinical studies suggest KPV may influence inflammatory pathways, including NF-κB signaling and the production of certain pro-inflammatory cytokines. It has been investigated in gastrointestinal, intestinal-barrier, immune, and dermatological research models.
Areas of Research
Inflammatory signaling
Gastrointestinal health
Intestinal-barrier function
Immune-response modulation
Skin inflammation
Inflammatory cytokine activity
GHK-Cu
Copper Tripeptide-1 • Glycyl-L-Histidyl-L-Lysine-Copper
GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma and other biological fluids. It has been researched extensively for its involvement in tissue remodeling, skin biology, collagen production, wound healing, and cellular repair processes.
Mechanism of Action GHK-Cu binds copper ions and has been investigated for its influence on collagen and extracellular-matrix production, antioxidant activity, gene expression, tissue remodeling, and wound-repair pathways.
Areas of Research
Collagen and elastin production
Skin remodeling and appearance
Wound healing
Tissue-repair processes
Antioxidant activity
Hair and follicle research
Extracellular-matrix remodeling
Why These Four Peptides Are Studied Together
The interest in combining GHK-Cu, BPC-157, TB-500, and KPV comes from their different areas of research. GHK-Cu is primarily associated with skin and tissue-remodeling research; BPC-157 and TB-500 are frequently investigated for tissue-repair and regenerative pathways; and KPV is primarily studied for inflammatory and immune signaling.
However, evidence for the combined KLOW formulation itself is not established through clinical trials, and findings involving one individual ingredient should not automatically be assumed to apply to the complete blend.
Research & Citations
BPC-157: Research includes preclinical studies examining gastrointestinal protection, tendon fibroblasts, wound healing, and tissue-repair pathways.
Thymosin Beta-4/TB-500: Research on thymosin beta-4 has examined cell migration, angiogenesis, wound healing, and tissue regeneration. Evidence specifically for TB-500 formulations is more limited.
KPV: Preclinical research has investigated KPV in inflammatory, gastrointestinal, intestinal-barrier, and immune-signaling models.
GHK-Cu: Research has examined GHK-Cu in relation to wound healing, collagen synthesis, skin remodeling, gene expression, and tissue regeneration.
Disclaimer: This information is for educational and research-reference purposes only. BPC-157, TB-500, and KPV are not FDA-approved medications for treating or preventing disease. Research findings, particularly from laboratory and animal studies, do not establish safety or effectiveness in humans. This information is not medical advice or a dosing recommendation.
Klow

Return & Refund Policy
Refund & Exchange Policy
We want you to feel confident when placing your order. Because our products are prepared and fulfilled specifically for each purchase, all sales are final once inventory has shipped.
Once an order has been shipped, we are unable to offer refunds, returns, exchanges, or cancellations.
If your order arrives damaged, defective, or incorrect, please contact us promptly after delivery with photos of the product and packaging so we can review the issue and work with you toward an appropriate resolution.
Please review your order carefully before completing your purchase, including the products, quantities, and shipping information.
By completing your purchase, you acknowledge and agree to this Refund & Exchange Policy.
